Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279

被引:35
作者
Leit, Silvana [1 ]
Greenwood, Jeremy [2 ]
Carriero, Samantha [1 ]
Mondal, Sayan [2 ]
Abel, Robert [2 ]
Ashwell, Mark [1 ]
Blanchette, Heather [1 ]
Boyles, Nicholas A. A. [2 ]
Cartwright, Mark [1 ]
Collis, Alan [1 ]
Feng, Shulu [2 ]
Ghanakota, Phani [2 ]
Harriman, Geraldine C. C. [1 ]
Hosagrahara, Vinayak [1 ]
Kaila, Neelu [1 ]
Kapeller, Rosanna [1 ]
Rafi, Salma B. B. [2 ]
Romero, Donna L. L. [1 ]
Tarantino, Paul M. M. [1 ]
Timaniya, Jignesh [3 ]
Toms, Angela V. V. [1 ]
Wester, Ronald T. T. [1 ]
Westlin, William [1 ]
Srivastava, Bhaskar [1 ]
Miao, Wenyan [1 ]
Tummino, Peter [1 ]
McElwee, Joshua J. J. [1 ]
Edmondson, Scott D. D. [1 ]
Masse, Craig E. E. [1 ]
机构
[1] Nimbus Therapeut, Boston, MA 02210 USA
[2] Schrodinger Inc, New York, NY 10036 USA
[3] Piramal Pharm Solut, Ahmadabad 382215, Gujarat, India
关键词
PSEUDOKINASE-DOMAIN; DRUG DISCOVERY; TYK2; IDENTIFICATION; PREDICTION; EFFICACY; MODELS; POLARIZATION; DERIVATIVES; ACCURATE;
D O I
10.1021/acs.jmedchem.3c00600
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
TYK2is a key mediator of IL12, IL23, and type I interferon signaling,and these cytokines have been implicated in the pathogenesis of multipleinflammatory and autoimmune diseases such as psoriasis, rheumatoidarthritis, lupus, and inflammatory bowel diseases. Supported by compellingdata from human genome-wide association studies and clinical results,TYK2 inhibition through small molecules is an attractive therapeuticstrategy to treat these diseases. Herein, we report the discoveryof a series of highly selective pseudokinase (Janus homology 2, JH2)domain inhibitors of TYK2 enzymatic activity. A computationally enableddesign strategy, including the use of FEP+, was instrumental in identifyinga pyrazolo-pyrimidine core. We highlight the utility of computationalphysics-based predictions used to optimize this series of moleculesto identify the development candidate 30, a potent, exquisitelyselective cellular TYK2 inhibitor that is currently in Phase 2 clinicaltrials for the treatment of psoriasis and psoriatic arthritis.
引用
收藏
页码:10473 / 10496
页数:24
相关论文
共 54 条
[1]   Accelerating drug discovery through tight integration of expert molecular design and predictive scoring [J].
Abel, Robert ;
Mondal, Sayan ;
Masse, Craig ;
Greenwood, Jeremy ;
Harriman, Geraldine ;
Ashwell, Mark A. ;
Bhat, Sathesh ;
Wester, Ronald ;
Frye, Leah ;
Kapeller, Rosana ;
Friesner, Richard A. .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2017, 43 :38-44
[2]   Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain [J].
Burke, James R. ;
Cheng, Lihong ;
Gillooly, Kathleen M. ;
Strnad, Joann ;
Zupa-Fernandez, Adriana ;
Catlett, Ian M. ;
Zhang, Yifan ;
Heimrich, Elizabeth M. ;
McIntyre, Kim W. ;
Cunningham, Mark D. ;
Carman, Julie A. ;
Zhou, Xiadi ;
Banas, Dana ;
Chaudhry, Charu ;
Li, Sha ;
D'Arienzo, Celia ;
Chimalakonda, Anjaneya ;
Yang, XiaoXia ;
Xie, Jenny H. ;
Pang, Jian ;
Zhao, Qihong ;
Rose, Shawn M. ;
Huang, Jinwen ;
Moslin, Ryan M. ;
Wrobleski, Stephen T. ;
Weinstein, David S. ;
Salter-Cid, Luisa M. .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (502)
[3]   Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility [J].
Couturier, Nicolas ;
Bucciarelli, Florence ;
Nurtdinov, Ramil N. ;
Debouverie, Marc ;
Lebrun-Frenay, Christine ;
Defer, Gilles ;
Moreau, Thibault ;
Confavreux, Christian ;
Vukusic, Sandra ;
Cournu-Rebeix, Isabelle ;
Goertsches, Robert H. ;
Zettl, Uwe K. ;
Comabella, Manuel ;
Montalban, Xavier ;
Rieckmann, Peter ;
Weber, Frank ;
Mueller-Myhsok, Bertram ;
Edan, Gilles ;
Fontaine, Bertrand ;
Mars, Lennart T. ;
Saoudi, Abdelhadi ;
Oksenberg, Jorge R. ;
Clanet, Michel ;
Liblau, Roland S. ;
Brassat, David .
BRAIN, 2011, 134 :693-703
[4]   Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity [J].
Dendrou, Calliope A. ;
Cortes, Adrian ;
Shipman, Lydia ;
Evans, Hayley G. ;
Attfield, Kathrine E. ;
Jostins, Luke ;
Barber, Thomas ;
Kaur, Gurman ;
Kuttikkatte, Subita Balaram ;
Leach, Oliver A. ;
Desel, Christiane ;
Faergeman, Soren L. ;
Cheeseman, Jane ;
Neville, Matt J. ;
Sawcer, Stephen ;
Compston, Alastair ;
Johnson, Adam R. ;
Everett, Christine ;
Bell, John I. ;
Karpe, Fredrik ;
Ultsch, Mark ;
Eigenbrot, Charles ;
McVean, Gil ;
Fugger, Lars .
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (363)
[5]   TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits [J].
Diogo, Dorothee ;
Bastarache, Lisa ;
Liao, Katherine P. ;
Graham, Robert R. ;
Fulton, Robert S. ;
Greenberg, Jeffrey D. ;
Eyre, Steve ;
Bowes, John ;
Cui, Jing ;
Lee, Annette ;
Pappas, Dimitrios A. ;
Kremer, Joel M. ;
Barton, Anne ;
Coenen, Marieke J. H. ;
Franke, Barbara ;
Kiemeney, Lambertus A. ;
Mariette, Xavier ;
Richard-Miceli, Corrine ;
Canhao, Helena ;
Fonseca, Joao E. ;
de Vries, Niek ;
Tak, Paul P. ;
Crusius, J. Bart A. ;
Nurmohamed, Michael T. ;
Kurreeman, Fina ;
Mikuls, Ted R. ;
Okada, Yukinori ;
Stahl, Eli A. ;
Larson, David E. ;
Deluca, Tracie L. ;
O'Laughlin, Michelle ;
Fronick, Catrina C. ;
Fulton, Lucinda L. ;
Kosoy, Roman ;
Ransom, Michael ;
Bhangale, Tushar R. ;
Ortmann, Ward ;
Cagan, Andrew ;
Gainer, Vivian ;
Karlson, Elizabeth W. ;
Kohane, Isaac ;
Murphy, Shawn N. ;
Martin, Javier ;
Zhernakova, Alexandra ;
Klareskog, Lars ;
Padyukov, Leonid ;
Worthington, Jane ;
Mardis, Elaine R. ;
Seldin, Michael F. ;
Gregersen, Peter K. .
PLOS ONE, 2015, 10 (04)
[6]   The psoriasis-protective TYK2 I684S variant impairs IL-12 stimulated pSTAT4 response in skin-homing CD4+and CD8+memory T-cells [J].
Enerback, C. ;
Sandin, C. ;
Lambert, S. ;
Zawistowski, M. ;
Stuart, P. E. ;
Verma, D. ;
Tsoi, L. C. ;
Nair, R. P. ;
Johnston, A. ;
Elder, J. T. .
SCIENTIFIC REPORTS, 2018, 8
[7]  
Faezi ST., 2018, RHEUMATOL RES, V3, P151, DOI [10.22631/rr.2018.69997.1057, DOI 10.22631/RR.2018.69997.1057]
[8]   Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-(1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841) [J].
Fensome, Andrew ;
Ambler, Catherine M. ;
Arnold, Eric ;
Banker, Mary Ellen ;
Brown, Matthew F. ;
Chrencik, Jill ;
Clark, James D. ;
Dowty, Martin E. ;
Efremov, Ivan V. ;
Flick, Andrew ;
Gerstenberger, Brian S. ;
Gopalsamy, Ariamala ;
Hayward, Matthew M. ;
Hegen, Martin ;
Hollingshead, Brett D. ;
Jussif, Jason ;
Knafels, John D. ;
Limburg, David C. ;
Lin, David ;
Lin, Tsung H. ;
Pierce, Betsy S. ;
Saiah, Eddine ;
Sharma, Raman ;
Symanowicz, Peter T. ;
Telliez, Jean-Baptiste ;
Trujillo, John I. ;
Vajdos, Felix F. ;
Vincent, Fabien ;
Wan, Zhao-Kui ;
Xing, Li ;
Yang, Xiaojing ;
Yang, Xin ;
Zhang, Liying .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (19) :8597-8612
[9]   Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy [J].
Friesner, RA ;
Banks, JL ;
Murphy, RB ;
Halgren, TA ;
Klicic, JJ ;
Mainz, DT ;
Repasky, MP ;
Knoll, EH ;
Shelley, M ;
Perry, JK ;
Shaw, DE ;
Francis, P ;
Shenkin, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1739-1749
[10]   Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases [J].
Gerstenberger, Brian S. ;
Ambler, Catherine ;
Arnold, Eric P. ;
Banker, Mary-Ellen ;
Brown, Matthew F. ;
Clark, James D. ;
Dermenci, Alpay ;
Dowty, Martin E. ;
Fensome, Andrew ;
Fish, Susan ;
Hayward, Matthew M. ;
Hegen, Martin ;
Hollingshead, Brett D. ;
Knafels, John D. ;
Lin, David W. ;
Lin, Tsung H. ;
Owen, Dafydd R. ;
Saiah, Eddine ;
Sharma, Raman ;
Vajdos, Felix F. ;
Xing, Li ;
Yang, Xiaojing ;
Yang, Xin ;
Wright, Stephen W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) :13561-13577